NCT01842256

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

A Randomized, Open-label, Single Dose, Two-treatment, Two-period, Two-sequence Crossover Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin After Oral Administration in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the effect of telmisartan/s-amlodipine on the pharmacokinetic properties of atorvastatin.

Detailed description

healthy subjects are administrated single-dose over the period Ⅰand Ⅱ(Crossover) of telmisartan/s-amlodipine, atorvastatin and atorvastatin.

Conditions

• Essential Hypertension
• Hyperlipidemia

Interventions

Type	Name	Description
DRUG	Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg	* 3 Tablets (telmisartan 80mg, amlodipine 5mg, atorvastatin 40mg each one), * oral intake, once in a period * over the period Ⅰ\&Ⅱ(crossover)
DRUG	atorvastatin 40mg	* 1 Tablet (atorvastatin 40mg), * oral intake, once in a period * over the period Ⅰ\&Ⅱ(crossover)

Timeline

• Start date: 2013-04-01
• Primary completion: 2013-05-01
• Completion: 2013-07-01
• First posted: 2013-04-29
• Last updated: 2013-08-01

Locations

1 site across 1 country: South Korea